Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients
| Autor: | Marta Cabezón, Cristian Morales, Mónica S. Ventura Ferreira, Natalia Estrada, Rolando Vallansot, Silvia Marcé, Lurdes Zamora, Miguel Sagüés, Concepción Boqué, Fabian Beier, Tim H. Brümmendorf, Olga García, Blanca Xicoy |
|---|---|
| Přispěvatelé: | Institut Català de la Salut, [Estrada N] Myeloid Neoplasms Research Group, Josep Carreras Leukemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona, Spain. [Xicoy B, Garcia O, Marcé S, Cabezón M, Zamora L] Myeloid Neoplasms Research Group, Josep Carreras Leukemia Research Institute, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona, Spain. Hematology Department, Institut Català d'Oncologia (ICO)-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras, Universitat Autònoma de Barcelona, Spain. [Beier F, Ventura Ferreira MS, Brümmendorf TH] Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, Uniklinik RWTH Aachen University, Germany. [Morales C] Core-Hematology Department, Clinical Laboratory ICS-Metropolitan Nord, Hospital Germans Trias i Pujol, Badalona, Spain. [Boqué C] Hematology Department, Institut Català d'Oncologia - Hospital Duran i Reynals, Hospitalet de Llobregat, Spain. [Sagüés M] Department d’Hematologia, Institut Català d'Oncologia Hospital Universitari de Girona Doctor Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain. [Vallansot R] Hematology Department, Institut Català d'Oncologia-Hospital Universitari Joan XXIII, Tarragona, Spain, Hospital Universitari de Girona Dr Josep Trueta |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Oncology
medicine.medical_specialty Leucèmia mieloide fenómenos fisiológicos celulares::ciclo celular::división celular::homeostasis telomérica [FENÓMENOS Y PROCESOS] Disease Therapeutics Leucèmia mieloide crònica Organic Chemicals::Amides::Benzamides::Imatinib Mesylate [CHEMICALS AND DRUGS] Article Neoplasms::Neoplasms by Histologic Type::Leukemia::Leukemia Myeloid::Leukemia Myelogenous Chronic BCR-ABL Positive [DISEASES] Internal medicine hemic and lymphatic diseases medicine Diseases of the blood and blood-forming organs Cell Physiological Phenomena::Cell Cycle::Cell Division::Telomere Homeostasis [PHENOMENA AND PROCESSES] Telòmer business.industry Myeloid leukemia Imatinib Hematology Telomere Terapèutica Discontinuation Real-time polymerase chain reaction Molecular Response compuestos orgánicos::amidas::benzamidas::mesilato de imatinib [COMPUESTOS QUÍMICOS Y DROGAS] RC633-647.5 business Tyrosine kinase neoplasias::neoplasias por tipo histológico::leucemia::leucemia mieloide::leucemia mielogenosa crónica BCR-ABL positiva [ENFERMEDADES] medicine.drug |
| Zdroj: | Scientia HemaSphere, Vol 5, Iss 12, p e657 (2021) HemaSphere Dipòsit Digital de la UB Universidad de Barcelona HemaSphere : open access journal of the European Hematology Association 5(12), e657 (2021). doi:10.1097/HS9.0000000000000657 |
| ISSN: | 0000-0000 |
| DOI: | 10.1097/HS9.0000000000000657 |
| Popis: | HemaSphere : open access journal of the European Hematology Association 5(12), e657 (2021). doi:10.1097/HS9.0000000000000657 Published by Wolters Kluwer Health, [Philadelphia, Pennsylvania] |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|